Mark Scott is an associate in the firm’s Chicago office. His practice focuses on litigation, particularly Hatch-Waxman litigation for generic pharmaceutical companies.

Previously, Mark was a commercialization analyst for the University of Illinois, where he evaluated cutting-edge University research for patentability, marketability and commercialization potential.